Skip to content

Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.

Featured In Neuroscience

Massachusetts General Hospital physician-scientist Patricia Musolino, MD, PhD, was a key investigator in a clinical trial that led to the first FDA-approved gene therapy for a cerebral disease. Her research is focused on studying rare genetic disorders to develop approaches that may lead to gene therapy treatments.

Featured In Research and Innovation

The Comprehensive Sickle Cell Disease Treatment Center at Massachusetts General Hospital will serve as an authorized treatment center for an FDA-approved gene therapy for sickle cell disease.

Featured In Ophthalmology

Jae-Hyun Jung, PhD, Sujin Kim, PhD, and Shui'er Han, PhD, determined "visual rivalry" interfered with the use of a head-mounted device for a virtual reality application that called for movement (walking), and they present suggestions for improved design.

Featured In Endocrinology

Massachusetts General Hospital researchers found that infants who have in utero exposure to maternal SARS-CoV-2 exhibit lower birth weight followed by accelerated weight gain in the first year of life, a pattern thought to increase the risk of obesity and cardiometabolic disease in childhood and adulthood.

Featured In Urology

In a multicenter case–control study, Massachusetts General Hospital researchers validated a new urinary comprehensive genomic profiling test, which requires only a urine specimen, for detecting urothelial carcinoma in patients with hematuria and predicting recurrence before clinical signs or symptoms appear.

The Latest Oncology Advances

Researchers at Massachusetts General Hospital are developing computation models capable of increasing the precision of targeted delivery of radiotherapy to liver tumors.

Leslie R. Lamb, MD, MSc, Constance D. Lehman, MD, PhD, and colleagues have demonstrated that a mammogram-based deep learning risk stratification model is more likely than traditional breast cancer risk models to identify women who will benefit from supplemental screening with breast MRI.

Contributing Physicians

Director of Translational Research, Urologic Surgeon, Department of Urology, Massachusetts General Hospital, Director, Prostate Cancer Genetics Program, Mass General Cancer Center, Assistant Professor of Surgery, Harvard Medical School

Dr. Salari

Director, Central Nervous System Metastasis Center, Mass General Cancer Center, Associate Professor of Medicine, Harvard Medical School

Priscilla K. Brastianos, MD

Advances Specialties

Digestive Health

A patient presented with severe malnutrition and an unintentional estimated weight loss of 160 pounds over three years. The Pathways Consult Service at Massachusetts General Hospital investigated the patient's concomitant skeletal and smooth muscle inflammation and gut dysmotility.

Neuroscience

In 2021, a randomized controlled trial showed heated yoga outperformed a waitlist control in a group of women with mild-to-moderate depression. Researchers at Massachusetts General Hospital have extended the findings to a larger, mixed-gender, and more severely depressed population.

Orthopaedics

A patient presented with severe malnutrition and an unintentional estimated weight loss of 160 pounds over three years. The Pathways Consult Service at Massachusetts General Hospital investigated the patient's concomitant skeletal and smooth muscle inflammation and gut dysmotility.

Education & Training Opportunities

February 10-14, 2024

The Society for Maternal-Fetal Medicine's Annual Meeting, The Pregnancy Meeting™, is the premier event for cutting-edge science in obstetrics where participants can connect with colleagues in maternal-fetal medicine. Learn about the research presented by the Department of Obstetrics and Gynecology at Massachusetts General Hospital.

February 12-16, 2024

Specialists from the Massachusetts General Hospital Department of Orthopaedic Surgery will present on leading research and innovative treatment approaches at the American Academy of Orthopaedic Surgeons 2024 Annual Meeting.